Pharming Group
€0.87Change from previous close: −1.76%Absolute change: −€0.02
Valuation
Data as of October 4, 2026
Valuation multiples
- Market cap
- €615.91M
- Enterprise value
- €570.93M
- P/E (trailing 12 months)
- 87.0
- Forward P/E
- 35.0
- Price/book
- 2.65
- Price/sales
- 1.68
- EV/EBITDA
- 17.4
- EV/revenue
- 1.56
Profitability and growth
- Gross margin
- 86.5%
- Operating margin
- 1.5%
- Net margin
- 2.5%
- ROE
- 3.6%
- ROA
- 3.5%
- Revenue growth (year over year)
- -3.2%
- Earnings growth (year over year)
- -62.9%
Financial health
- Total cash
- €158.28M
- Total debt
- €113.3M
- Debt/equity
- 0.42
- Current ratio
- 3.01
- Quick ratio
- 2.31
Dividends
- Payout ratio
- 0.0%
Analysts and estimates
- Average price target
- €2.24
- Median price target
- €2.24
- High price target
- €2.47
- Low price target
- €2.01
- Analysts with a price target
- 3
- Consensus
- Buy
- Forward EPS
- €0.02
- EPS estimate, current year
- €0.03
Shares and trading
- Beta
- 0.07
- Average volume
- 9.1M
- Shares outstanding
- 707.78M
- Float
- 696.57M
- Institutional ownership
- 23.4%
- Insider ownership
- 1.9%